We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why You Should Buy Albemarle (ALB) Stock Right Now
Read MoreHide Full Article
Shares of Albemarle Corporation (ALB - Free Report) have shot up around 46% over the past six months. The company is benefiting from higher lithium prices and volumes, capacity expansion and cost-saving actions.
We are positive on the company’s prospects and believe that the time is right for you to add the stock to portfolio as it looks promising and is poised to carry the momentum ahead.
Let’s delve deeper into the factors that make this Zacks Rank #1 (Strong Buy) stock an attractive choice for investors right now.
An Outperformer
Shares of Albemarle have popped 56.6% year to date against the 12.9% rise of its industry. It has also outperformed the S&P 500’s 25.4% rise over the same period.
Image Source: Zacks Investment Research
Positive Earnings Surprise History
Albemarle has outpaced the Zacks Consensus Estimate in each of the trailing four quarters. In this time frame, it has delivered an earnings surprise of roughly 22.1%, on average.
Estimates Going Up
Over the past two months, the Zacks Consensus Estimate for Albemarle for 2021 has increased around 12.7%. The consensus estimate for fourth-quarter 2021 has also been revised 15.7% upward over the same time frame. The favorable estimate revisions instill investor confidence in the stock.
Growth Drivers in Place
Albemarle is benefiting from higher volumes in its lithium business on continued recovery in global economic activities. Healthy customer orders and plant productivity improvements are supporting volumes. Higher lithium prices due to tight market conditions are also supporting its performance. Its bromine business is also gaining from higher demand, a rebound in certain end markets, higher pricing and cost-saving actions. Albemarle is seeing strong demand for flame retardants.
The company is also strategically executing its projects aimed at boosting its global lithium derivative capacity. It remains focused on investing in high-return projects to drive productivity. The company is well placed to gain from long-term growth in the battery-grade lithium market.
Albemarle is also benefiting from cost-saving and productivity initiatives. Its cost actions are expected to support its margins. The company expects to achieve $75 million of productivity improvement on a year-over-year basis in 2021.
The company also remains committed to deliver incremental returns to its shareholders. It has raised its annual dividend for the 27th straight year. Albemarle remains focused on maintaining its dividend payout. The company also remains committed to maintain adequate financial flexibility with ample liquidity. It had liquidity of around $2 billion at the end of the third quarter of 2021.
Nutrien has an expected earnings growth rate of 233.3% for the current year. The Zacks Consensus Estimate for NTR's current-year earnings has been revised 18.1% upward over the last 60 days.
Nutrien beat the Zacks Consensus Estimate for earnings in three of the last four quarters while missing once. It has a trailing four-quarter earnings surprise of roughly 73.5%, on average. NTR has rallied around 49% in a year.
AdvanSix has a projected earnings growth rate of 194.5% for the current year. ASIX's consensus estimate for the current year has been revised 5.9% upward over the last 60 days.
AdvanSix beat the Zacks Consensus Estimate for earnings in each of the trailing four quarters, the average being 46.9%. ASIX has rallied around 114% in a year.
Intrepid Potash has a projected earnings growth rate of 244.7% for the current year. The consensus estimate for IPI’s current year has been revised 3.3% upward over the last 60 days.
Intrepid Potash beat the Zacks Consensus Estimate for earnings in three of the last four quarters while missing once. It has a trailing four-quarter earnings surprise of roughly 132.9%, on average. IPI shares have surged around 157% in a year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Here's Why You Should Buy Albemarle (ALB) Stock Right Now
Shares of Albemarle Corporation (ALB - Free Report) have shot up around 46% over the past six months. The company is benefiting from higher lithium prices and volumes, capacity expansion and cost-saving actions.
We are positive on the company’s prospects and believe that the time is right for you to add the stock to portfolio as it looks promising and is poised to carry the momentum ahead.
Let’s delve deeper into the factors that make this Zacks Rank #1 (Strong Buy) stock an attractive choice for investors right now.
An Outperformer
Shares of Albemarle have popped 56.6% year to date against the 12.9% rise of its industry. It has also outperformed the S&P 500’s 25.4% rise over the same period.
Positive Earnings Surprise History
Albemarle has outpaced the Zacks Consensus Estimate in each of the trailing four quarters. In this time frame, it has delivered an earnings surprise of roughly 22.1%, on average.
Estimates Going Up
Over the past two months, the Zacks Consensus Estimate for Albemarle for 2021 has increased around 12.7%. The consensus estimate for fourth-quarter 2021 has also been revised 15.7% upward over the same time frame. The favorable estimate revisions instill investor confidence in the stock.
Growth Drivers in Place
Albemarle is benefiting from higher volumes in its lithium business on continued recovery in global economic activities. Healthy customer orders and plant productivity improvements are supporting volumes. Higher lithium prices due to tight market conditions are also supporting its performance. Its bromine business is also gaining from higher demand, a rebound in certain end markets, higher pricing and cost-saving actions. Albemarle is seeing strong demand for flame retardants.
The company is also strategically executing its projects aimed at boosting its global lithium derivative capacity. It remains focused on investing in high-return projects to drive productivity. The company is well placed to gain from long-term growth in the battery-grade lithium market.
Albemarle is also benefiting from cost-saving and productivity initiatives. Its cost actions are expected to support its margins. The company expects to achieve $75 million of productivity improvement on a year-over-year basis in 2021.
The company also remains committed to deliver incremental returns to its shareholders. It has raised its annual dividend for the 27th straight year. Albemarle remains focused on maintaining its dividend payout. The company also remains committed to maintain adequate financial flexibility with ample liquidity. It had liquidity of around $2 billion at the end of the third quarter of 2021.
Stocks to Consider
Other top-ranked stocks worth considering in the basic materials space include Nutrien Ltd. (NTR - Free Report) , AdvanSix Inc. (ASIX - Free Report) and Intrepid Potash, Inc. (IPI - Free Report) , each sporting a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.
Nutrien has an expected earnings growth rate of 233.3% for the current year. The Zacks Consensus Estimate for NTR's current-year earnings has been revised 18.1% upward over the last 60 days.
Nutrien beat the Zacks Consensus Estimate for earnings in three of the last four quarters while missing once. It has a trailing four-quarter earnings surprise of roughly 73.5%, on average. NTR has rallied around 49% in a year.
AdvanSix has a projected earnings growth rate of 194.5% for the current year. ASIX's consensus estimate for the current year has been revised 5.9% upward over the last 60 days.
AdvanSix beat the Zacks Consensus Estimate for earnings in each of the trailing four quarters, the average being 46.9%. ASIX has rallied around 114% in a year.
Intrepid Potash has a projected earnings growth rate of 244.7% for the current year. The consensus estimate for IPI’s current year has been revised 3.3% upward over the last 60 days.
Intrepid Potash beat the Zacks Consensus Estimate for earnings in three of the last four quarters while missing once. It has a trailing four-quarter earnings surprise of roughly 132.9%, on average. IPI shares have surged around 157% in a year.